Veterinary Clinical Pathology Director

Bristol-Myers Squibb Co; New Brunswick (NJ); Hybrid; USD 239,000 - 290,000; Full time

Benefits offered by this job

Flexible Time Off

11 paid holidays

Vacation entitlement (160 hours)

Job summary

Bristol Myers Squibb is seeking a Veterinary Clinical Pathologist to join a large biopharmaceutical company focused on safe, efficacious medicines for unmet needs. You will work within a collaborative, experienced pathologist team and be encouraged to grow your career.

Responsibilities include interpreting clinical pathology data, contributing to regulatory submissions, and leading cross-functional efforts. Hybrid work in New Brunswick, NJ is supported with a strong scientific culture.

Qualifications

• DVM with ACVP Board Certification in Clinical Pathology (or board-eligible) required.
• MS or PhD preferred.
• Strong foundation in industry clinical pathology, toxicology, and related disciplines.

Responsibilities

• Provide expert interpretation and integration of clinical pathology data from nonclinical studies.
• Serve as scientific advisor to the Clinical Pathology laboratory in New Brunswick and collaborate with NDDS.
• Review non-GLP and GLP study protocols and contribute to endpoint design.
• Prepare clear, scientifically rigorous clinical pathology reports for regulatory submissions.
• Act as independent reviewer for outsourced toxicology studies.

Skills

Clinical pathology interpretation

Nonclinical data analysis

Regulatory submissions support

Cross-functional collaboration

Scientific reporting

GLP knowledge

Leadership potential

Communication skills

Education

DVM with ACVP Board Certification in Clinical Pathology

MS/PhD preferred

Job description

Bristol Myers Squibb is seeking a Veterinary Clinical Pathologist to join a large biopharmaceutical company focused on safe, efficacious medicines for unmet needs. You will work within a collaborative, experienced pathologist team and be encouraged to grow your career.

Responsibilities include interpreting clinical pathology data, contributing to regulatory submissions, and leading cross-functional efforts. Hybrid work in New Brunswick, NJ is supported with a strong scientific culture.